{
    "organizations": [],
    "uuid": "67306ddd40b7436c9ed829ea9f9fa12e2058f7e2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-strides-shasun-gets-us-fda-approva/brief-strides-shasun-gets-u-s-fda-approval-for-piroxicam-capsules-idUSFWN1PP1IO",
    "ord_in_thread": 0,
    "title": "BRIEF-Strides Shasun Gets U.S. FDA Approval For Piroxicam Capsules",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Strides Shasun Ltd:\n* SAYS CO GETS U.S. FDA APPROVAL FOR PIROXICAM CAPSULES * PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT BANGALORE; WILL BE MARKETED BY STRIDES PHARMA IN U.S. MARKET Source text - bit.ly/2EqTVGU Further company coverage:\n ",
    "published": "2018-01-31T12:45:00.000+02:00",
    "crawled": "2018-01-31T16:16:56.025+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "stride",
        "shasun",
        "ltd",
        "say",
        "co",
        "get",
        "fda",
        "approval",
        "piroxicam",
        "capsule",
        "product",
        "manufactured",
        "co",
        "oral",
        "dosage",
        "facility",
        "bangalore",
        "marketed",
        "stride",
        "pharma",
        "market",
        "source",
        "text",
        "company",
        "coverage"
    ]
}